keyword
https://read.qxmd.com/read/38586547/a-paradigm-shift-in-non-small-cell-lung-cancer-nsclc-diagnostics-from-single-gene-tests-to-comprehensive-genomic-profiling
#21
JOURNAL ARTICLE
Ushna Zameer, Wajiha Shaikh, Abdul Moiz Khan
Lung cancer imposes a burden on the health care system worldwide affecting 2 million people and causing 1.8 million deaths in 2021.More than 85% of all lung cancer cases are reported under Non-small-cell lung cancer (NSCLC). It is critical to discover gene alterations to treat non-small cell lung cancer successfully. The CAP/IASLC/AMP recommendations supported use of polymerase chain reaction (PCR) and fluorescent in situ hybridization (FISH) EGFR (epidermal growth factor receptor) mutations and ALK (Anaplastic lymphoma kinase) rearrangements, respectively...
2024: Cancer Informatics
https://read.qxmd.com/read/38583500/nurse-led-psychological-interventions-for-depression-in-adult-cancer-patients-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#22
REVIEW
Dominique Cranstoun, Michael Baliousis, Hannah Lena Merdian, Mike Rennoldson
OBJECTIVES: Depression, frequently associated with cancer, significantly impacts health outcomes, necessitating effective treatments. This systematic review and meta-analysis aim to synthesise and critically evaluate the evidence from Randomised Controlled Trials (RCTs) for the efficacy of nurse-led psychological interventions in managing depression among adult cancer patients. It focuses on the unique contribution of these interventions to improving depression management in oncology care, an underrepresented area in the existing literature...
April 5, 2024: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38583496/carotid-artery-stenosis-and-ischemic-stroke-in-patients-with-head-and-neck-cancer-treated-with-radiotherapy-a-critical-review
#23
REVIEW
Justin Smith, Danielle Margalit, Jonathan Golledge, Domenico Nastasi, Anju Nohria, Lachlan McDowell
PURPOSE: The purpose of this review is to summarize the literature on carotid artery stenosis (CAS) and ischemic stroke (IS) in head and neck cancer (HNC) patients treated with radiotherapy (RT) to guide assessment, screening, and management strategies. RESULTS: Patients treated with RT for HNC are at an elevated risk of developing CAS with published meta-analyses demonstrating that CAS >50% occurs in approximately 25% of patients. Previous research suggests a 10-year cumulative incidence of stroke between 5...
April 5, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38582227/patient-reported-outcomes-in-randomized-clinical-trials-of-systemic-therapy-for-advanced-soft-tissue-sarcomas-in-adults-a-systematic-review
#24
REVIEW
Evelyne Roets, Winette van der Graaf, Bauke H G van Riet, Rick L Haas, Eugenie Younger, Francesco Sparano, Roger Wilson, Stevie van der Mierden, Neeltje Steeghs, Fabio Efficace, Olga Husson
BACKGROUND: This systematic review evaluates reporting of patient-reported outcomes (PROs) within randomized clinical trials (RCTs) for advanced soft tissue sarcoma (STS) patients. METHODS: A systematic literature search from January 2000 - August 2022 was conducted for phase II/III RCTs evaluating systemic treatments in adult patients with advanced STS. Quality of PRO reporting was assessed using the CONSORT PRO extension. RESULTS: Out of 7294 abstracts, 59 articles were included; comprising 43 RCTs...
April 4, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38581754/perioperative-complications-and-in-hospital-mortality-in-radical-cystectomy-patients-with-heart-valve-replacement
#25
JOURNAL ARTICLE
Carolin Siech, Andrea Baudo, Mario de Angelis, Letizia Maria Ippolita Jannello, Francesco Di Bello, Jordan A Goyal, Zhe Tian, Fred Saad, Shahrokh F Shariat, Nicola Longo, Luca Carmignani, Ottavio de Cobelli, Alberto Briganti, Marina Kosiba, Philipp Mandel, Luis A Kluth, Felix K H Chun, Pierre I Karakiewicz
PURPOSE: To assess in-hospital mortality and complication rates after radical cystectomy (RC) in patients with history of heart-valve replacement. MATERIALS AND METHODS: Using the National Inpatient Sample (2000-2019), non-metastatic bladder cancer patients undergoing RC were stratified according to history of heart-valve replacement. Regression models (RM) predicted hospital outcomes. RESULTS: Of 25,535 RC patients, 250 (1.0%) harbored history of heart-valve replacement...
March 28, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38578003/reproductive-concerns-and-associated-factors-among-adolescent-and-young-adult-cancer-survivors-in-uganda-a-hospital-based-cross-sectional-study
#26
JOURNAL ARTICLE
Richard Nyeko, Nelson Okello, Christine Joy Abeja, Proscovia Adyanga, Betty Apio, Caroline Kambugu Nabasirye, Pamella Aol Mwa, Racheal Angom, Fadhil Geriga, Julie Buser
Purpose: Reproductive health (RH) is a critical issue among cancer survivors worldwide. However, in developing countries where RH services for patients with cancer are often lacking, reproductive concerns among adolescent and young adult (AYA) survivors remain uncertain. In this study, we assessed the reproductive concerns of AYA cancer survivors in a resource-limited context of Uganda. Methods: We collected data from AYA cancer survivors at two facilities in Uganda using an interviewer-administered questionnaire...
April 5, 2024: Journal of Adolescent and Young Adult Oncology
https://read.qxmd.com/read/38576591/leveraging-electrochemical-sensors-to-improve-efficiency-of-cancer-detection
#27
EDITORIAL
Li Fu, Hassan Karimi-Maleh
Electrochemical biosensors have emerged as a promising technology for cancer detection due to their high sensitivity, rapid response, low cost, and capability for non-invasive detection. Recent advances in nanomaterials like nanoparticles, graphene, and nanowires have enhanced sensor performance to allow for cancer biomarker detection, like circulating tumor cells, nucleic acids, proteins and metabolites, at ultra-low concentrations. However, several challenges need to be addressed before electrochemical biosensors can be clinically implemented...
March 24, 2024: World Journal of Clinical Oncology
https://read.qxmd.com/read/38574419/identifying-the-unmet-needs-of-post-treatment-colorectal-cancer-survivors-a-critical-literature-review
#28
REVIEW
Xingjuan Luo, Haiying Xu, Yanting Zhang, Sirun Liu, Shan Xu, Yali Xie, Juan Xiao, Tingting Hu, Hong Xiao
PURPOSE: Following treatment completion, colorectal cancer (CRC) survivors experience various unmet needs. This review aims to synthesize the unmet needs of CRC survivors after treatment and to identify demographic, disease or treatment-related, healthcare-related, and psychosocial factors correlated with unmet needs. METHOD: English or Chinese articles that focused on CRC survivors' post-treatment unmet needs were systematically searched from the five electronic databases, which included CINAHL, PubMed, Embase, PsycINFO, and the China Academic Journal Full-text Database, from the launch of databases to July 2023...
March 21, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/38571990/successful-use-of-intravenous-methylnaltrexone-for-opioid-induced-constipation-in-critically-ill-pediatric-patients
#29
JOURNAL ARTICLE
Kimberly P Mills, Christopher C McPherson, Ahmed S Said, Michael A Lahart
Objectives  Methylnaltrexone is U.S. Food and Drug Administration (FDA) approved as a subcutaneous injection for adults with opioid-induced constipation (OIC). Case series have described the use of methylnaltrexone for OIC in the pediatric oncology population. There are limited data describing its intravenous use in critically ill pediatric patients. Methods  We conducted a retrospective observational study at St. Louis Children's Hospital. Patients less than 18 years old who received at least one dose of intravenous methylnaltrexone while admitted to an intensive care unit between January 2016 and August 2019 were included...
March 2024: Journal of Pediatric Intensive Care
https://read.qxmd.com/read/38570403/retention-rates-and-reasons-for-non-retention-in-exercise-oncology-trials-in-the-post-treatment-phase-a-systematic-review
#30
REVIEW
S Hu, E Guinan, D Mockler, L O'Neill
PURPOSE: Retention is a key marker of trial success. Poor retention can induce bias, reduce statistical power and minimise the validity of trials. This review examined retention rates in exercise trials in cancer survivors, reasons for non-retention and retention strategies utilised. METHODS: A systematic review was conducted using a predefined search strategy in EMBASE RCTs, MEDLINE OVID, CINAHL, Web of Science-Core Collection and Cochrane Central Register of Controlled Trials (CENTRAL)...
April 3, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38570271/variation-in-management-of-lymph-node-positive-prostate-cancer-after-radical-prostatectomy-within-a-statewide-quality-improvement-consortium
#31
JOURNAL ARTICLE
Daniel Triner, Stephanie Daignault-Newton, Udit Singhal, Michael Sessine, Robert T Dess, Megan E V Caram, Tudor Borza, Kevin B Ginsburg, Brian R Lane, Todd M Morgan
BACKGROUND: Patients with lymph node positive (pN+) disease found at the time of radical prostatectomy with pelvic lymphadenectomy for clinically localized prostate cancer (CaP) are at high risk of disease persistence and progression. Contemporary management trends of pN+ CaP are not well described. MATERIALS AND METHODS: Patients in the Michigan Urologic Surgery Improvement Collaborative (MUSIC) with clinically localized prostate cancer who underwent radical prostatectomy between 2012 and 2023 with cN0/pN+ disease were identified...
April 2, 2024: Urologic Oncology
https://read.qxmd.com/read/38569162/current-status-and-issues-of-collaboration-between-physicians-and-pharmacists-in-fertility-preservation
#32
JOURNAL ARTICLE
Tadashi Maezawa, Masahito Yonemura, Kaede Baba, Hiroki Takeuchi, Miki Hioki, Ayako Nishimura, Hiroko Minatogawa, Tomoyuki Utano, Kazuma Amino, Masami Ito, Naohiro Akita, Tsuguo Iwatani, Nao Suzuki
Purpose: This study addresses the critical issue of fertility preservation among young patients with cancer in Japan, recognizing the brief decision-making window and the need for comprehensive support. Pharmacists, well-versed in the side effects of anticancer drugs, can play a vital role in this support process. However, the extent of pharmacists' involvement in fertility preservation remains unclear. We aimed to investigate pharmacists' roles in addressing cancer treatment-induced fertility concerns and their collaboration with physicians, offering insights into enhancing pharmacist participation in fertility preservation...
April 3, 2024: Journal of Adolescent and Young Adult Oncology
https://read.qxmd.com/read/38564338/electronic-health-intervention-to-manage-symptoms-of-immunotherapy-in-patients-with-cancer-sofia-results-from-a-randomized-controlled-pilot-trial
#33
JOURNAL ARTICLE
Christina Sauer, Stefanie Zschäbitz, Jürgen Krauss, Thomas Walle, Georg Martin Haag, Dirk Jäger, Kiriaki Hiller, Till Johannes Bugaj, Hans-Christoph Friederich, Imad Maatouk
BACKGROUND: For patients receiving immune checkpoint inhibitors, early detection of immune-related adverse events (irAEs) is critical for one's safety. To this end, a smartphone app (SOFIA) was developed that featured the assessment of electronic patient-reported outcomes (ePROs) focusing on irAEs as well as a set of comprehensive supportive information. Its feasibility and preliminary efficacy were evaluated in a randomized controlled trial (RCT). METHODS: Patients who received immune checkpoint inhibition therapy were randomly assigned to an intervention group (IG) or a control group (CG; care as usual)...
April 2, 2024: Cancer
https://read.qxmd.com/read/38560973/outcomes-and-long-term-survival-of-adolescent-and-young-adult-patients-admitted-to-the-intensive-care-unit-following-allogeneic-hematopoietic-stem-cell-transplantation-a-single-center-experience-of-152-patients
#34
JOURNAL ARTICLE
Othman M Solaiman, Tusneem Elhassan, Riad E Fakih, Abdul Mannan, Zainab Alduhailib, Ashwaq A Mahdali, Hazzaa Alzahrani, Mouhamad Jamil, Naeem Chaudhri, Alyaa Elhazmi, Mohammad Kolko, Fahad Z Al-Sharif, Abdullah Alrbiaan, Mohammed Shaban, Marwan Shaheen, Nawal Salahuddin, Feras A Alfraih, Ashraf S Altarifi, Mona Hassanein, Sulaiman Hosaini, Noura Alhashim, Alaa A Mohamed, Amr Hanbali, Ali H Aljanoubi, Nadia R Al-Obaidi, Walid Rasheed, Khalid Maghrabi, Fahad Almohareb, Ayman Soubani, Mahmoud Aljurf, Syed O Ahmed
BACKGROUND AND OBJECTIVES: Prognostic factors reliably predicting outcomes for critically ill adolescent and young adult (AYA) patients undergoing allogeneic hematopoietic cell transplantation (allo-HSCT) are lacking. We assessed transplant and intensive care unit (ICU)-related factors impacting patient outcomes. PATIENTS AND METHODS: AYA patients who underwent allo-HSCT and required ICU admission at a Tertiary care Centre, during the period of 2003-2013, were included in this retrospective review...
March 22, 2024: Hematology/oncology and Stem Cell Therapy
https://read.qxmd.com/read/38557117/hepatic-ablation-technology-assessment-of-conflicts-of-interest-in-recent-literature
#35
JOURNAL ARTICLE
Keshav Kooragayala, Matthew C Moccia, Frank Spitz, Austin Lenart, Tanay-Veer Gandhi, Manisha Koneru, Young Hong
INTRODUCTION: Collaboration between the health care industry and surgeons is critical in modern medicine. Conflict of interest (COI) has the risk of introducing bias into research studies. We investigated the accuracy of self-disclosed COI for studies that researched the use of microwave ablation for liver metastasis. METHODS: A literature search identified studies that investigated the use of microwave ablation for liver cancer between 2016 and 2022. We utilized the Open Payments Database to query individual authors' financial contributions from the industry...
April 1, 2024: American Surgeon
https://read.qxmd.com/read/38556719/implementation-of-a-light-therapy-team-to-administer-photobiomodulation-therapy-a-standardized-protocol-to-prevent-and-treat-oral-mucositis-in-the-pediatric-hematopoietic-stem-cell-transplant-population
#36
JOURNAL ARTICLE
Kathleen Magee, Jenell Robins, Sharon Staton, Gabriella Llaurador, Alexandra M Stevens
BACKGROUND: Oral mucositis (OM) is a painful and common complication of hematopoietic stem cell transplant (HSCT). The Children's Oncology Group recently published guidelines recommending photobiomodulation (PBM) for preventing and treating OM in pediatric HSCT patients. However, this is a rarely used intervention in pediatric hospitals. PROCEDURE: Patients undergoing allogeneic HSCT, or autologous HSCT for a neuroblastoma diagnosis, had PBM administered from the first day of conditioning to transplant Day +20...
March 31, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38554804/is-it-time-to-discard-the-diagnostic-and-statistical-manual-of-mental-disorders-dsm-in-psycho-oncology
#37
EDITORIAL
Darren Haywood, Roman Kotov, Robert F Krueger, Aidan G C Wright, Miriam K Forbes, Evan Dauer, Frank D Baughman, Susan L Rossell, Nicolas H Hart
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care approaches. The validity of a chosen conceptualisation of psychopathology is therefore paramount for ensuring cancer survivors receive high-quality and efficacious care and support that can be iteratively improved via coordinated research efforts. In this paper, we discuss the traditional diagnostic approach to conceptualising psychopathology within cancer care, including the diagnostic system the 'Diagnostic and Statistical Manual of Mental Disorders' (DSM) [1], and the significant issues it presents within cancer survivorship...
March 28, 2024: Cancer Letters
https://read.qxmd.com/read/38553653/association-between-medicaid-expansion-and-cutaneous-melanoma-diagnosis-and-outcomes-does-where-you-live-make-a-difference
#38
JOURNAL ARTICLE
Alicia C Greene, Olivia Ziegler, McKell Quattrone, Michael J Stack, Benjamin Becker, Colette R Pameijer, Chan Shen
BACKGROUND: Early detection and standardized treatment are crucial for enhancing outcomes for patients with cutaneous melanoma, the commonly diagnosed skin cancer. However, access to quality health care services remains a critical barrier for many patients, particularly the uninsured. Whereas Medicaid expansion (ME) has had a positive impact on some cancers, its specific influence on cutaneous melanoma remains understudied. METHODS: The National Cancer Database identified 87,512 patients 40-64 years of age with a diagnosis of non-metastatic cutaneous melanoma between 2004 and 2017...
March 29, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38547501/contextual-factors-influencing-the-equitable-implementation-of-precision-medicine-in-routine-cancer-care-in-belgium
#39
JOURNAL ARTICLE
Tugce Schmitt, Marie Delnord, Emilie Cauët, Els Van Valckenborgh, Marc Van den Bulcke
BACKGROUND: Precision medicine represents a paradigm shift in health systems, moving from a one-size-fits-all approach to a more individualized form of care, spanning multiple scientific disciplines including drug discovery, genomics, and health communication. This study aims to explore the contextual factors influencing the equitable implementation of precision medicine in Belgium for incorporating precision medicine into routine cancer care within the Belgian health system. METHODS: As part of a foresight study, our approach evaluates critical factors affecting the implementation of precision oncology...
March 28, 2024: European Journal of Public Health
https://read.qxmd.com/read/38547422/toward-informed-selection-and-interpretation-of-clinical-genomic-tests-in-prostate-cancer
#40
JOURNAL ARTICLE
Gillian Vandekerkhove, Veda N Giri, Susan Halabi, Christopher McNair, Khaldoun Hamade, Rhonda L Bitting, Alexander W Wyatt
Clinical genomic testing of patient germline, tumor tissue, or plasma cell-free DNA can enable a personalized approach to cancer management and treatment. In prostate cancer (PCa), broad genotyping tests are now widely used to identify germline and/or somatic alterations in BRCA2 and other DNA damage repair genes. Alterations in these genes can confer cancer sensitivity to poly (ADP-ribose) polymerase inhibitors, are linked with poor prognosis, and can have potential hereditary cancer implications for family members...
March 2024: JCO Precision Oncology
keyword
keyword
99205
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.